All In MedTech

Device Trial Radar · NCT07890233

Efficacy of an LED Mask

12-week Study Evaluating the Efficacy of an LED Mask

Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

110

Planned (sponsor's estimate)

Start

Nov 30, 2026

Primary completion

Mar 30, 2027

Study completion May 31, 2027

Sponsor

Lead sponsor
Therabody, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 22, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 25 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this interventional study is to evaluate the efficacy and perception a commercial LED device in 110 healthy adult females and males between the ages of 35-65 years old, inclusively. The main questions it aims to answer are: Does daily use of this commercial LED device improve overall skin appearance as measured by clinical tools (expert clinical grading, cutometer, digital photography, and VISIA-CR? Does daily use of this commercial LED device improve subjective skin appearance? Is daily use of this commercial LED device well tolerated? Participants will complete a 9-minute LED treatment (4.5 minutes LED, 4.5 minutes LED+ infrared light therapy) with a commercially available device every day for 12 weeks. They will visit the clinic three times (baseline, 6 weeks, 12 weeks) for clinical grading of skin.

Conditions

  • Fine Lines and Wrinkles
  • Skin Health
  • Skin Tone

Interventions

  • Light emitting diode treatmentDevice

    Participants will use the device for a 9-minute treatment (4.5 min red light and 4.5 minutes red + infrared light therapy) 7 days a week for 12 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Expert Clinical GradingTime frame: From enrollment to the end of treatment at 12 weeks

5 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • ALS Global Clinical Studies

    Purchase, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.